A recent study demonstrated that the integrin αvβ6–TGF-β–SOX4 pathway regulates multiple signaling events relevant for T cell–mediated tumor immunity in triple-negative breast cancer cells (95). Here, TGFB1 is linked to triple-negative breast carcinoma.